SCHEMBL18156720

SCHEMBL18156720

c1ccc(-c2cc(-c3ccc4c(c3)C3(c5ccccc5-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc53)c3ccc5c(oc6ccccc65)c3-4)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.36
ALDH1A1 P00352 6/20 0.36
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
HPGD P15428 4/20 0.36
LMNA P02545 4/20 0.36
KDM4E B2RXH2 3/20 0.36
GLA P06280 1/20 0.36
ALOX5 P09917 2/20 0.34
NTSR1 P30989 1/20 0.34
POLB P06746 2/20 0.32
TSHR P16473 2/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31
HSD17B10 Q99714 1/20 0.31
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22423114 1.00 MAPT (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL19008441 0.98 MAPT (0.35) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL20224303 0.97 MAPT (0.34) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17117663 0.97 ALOX5 (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL16855636 0.97 ALOX5 (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL18732069 0.96 ALOX5 (0.35) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL20224307 0.96 ALOX5 (0.35) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL18156717 0.96 ALOX5 (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL18156835 0.96 ALOX5 (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL16855610 0.96 ALOX5 (0.36) MAPTALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11545634-B2 Heterocyclic spiro compounds MERCK PATENT GMBH (DE) 2023-01-03 US disclosed
EP-3708634-A1 HETEROCYCLIC SPIRO COMPOUNDS Merck Patent GmbH (DE) 2020-09-16 EP disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
EP-3083880-B1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-04-01 EP disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 MAPT 3089/4885ALDH1A1 383/4885KMT2A 3328/4885
US-11545634-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 MAPT 3089/4885ALDH1A1 383/4885KMT2A 3328/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 MAPT 3089/4885ALDH1A1 383/4885KMT2A 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.